|

Fluthicasone / Vilanterol / Umeclidinium (100/25/62.5 mcg) Clinical Trials

1 actively recruiting trial

Also known as: TRELEGY

Pipeline

Phase 4: 1

Top Sponsors

  • National Institute of Respiratory Diseases, Mexico1

Indications

  • Pollution Related Respiratory Disorder1
  • COPD Bronchitis1
  • COPD1

Other1 trial

Effect of the Inhaled Triple Therapies Over the Small Airway in Biomass Exposure
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.